Feed HAWPF
HA
Haw Par Corporation Limited HAWPF OTC · Healthcare · Singapore
$9.85 +0.00% +$0.00
Depth
- Market cap
- $2.79B
- Enterprise value
- $2.18B
- P/E
- 12.2x
- Forward P/E
- -
- PEG
- 0.7x
- P/S
- 12.7x
- P/FCF
- 12.4x
- EV/EBITDA
- 29.8x
- ROIC
- 1.3%
- Gross margin
- 55.5%
- Net margin
- 104.4%
- Dividend yield
- 3.21%
- Payout ratio
- 39.1%
- Net debt/EBITDA
- -8.4x
- Beta
- 0.16
- Free float
- 62.2%
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 21% a year over the last 3 years.
- What to watch: Revenue growth is slowing: 8.1% a year over the last 3 years against 16% over 5 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 SGD of revenue, 104 SGD is left as net profit.
- What to watch: It earns only 1.3 SGD a year on every 100 SGD of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $667.9M against $52.5M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number